| Nov 20 |
Flagship, Pfizer alliance yields two more startup deals
|
| Nov 19 |
Pfizer cannot recoup $75 million from SEC insider trading settlement, judge rules
|
| Nov 19 |
BridgeBio Pharma's Acoramidis Shows Competitive Edge Against Pfizer's Tafamidisa In Lucrative But Competitive ATTR-CM Market
|
| Nov 19 |
ACRS Stock Up on Licensing Deal With Biosion for Two Immunology Drugs
|
| Nov 19 |
Pfizer (NYSE:PFE) stock falls 5.3% in past week as three-year earnings and shareholder returns continue downward trend
|
| Nov 19 |
These 4 Price-to-Sales Stocks Can Supercharge Your Portfolio Growth
|
| Nov 19 |
Pfizer, Arvinas delay late-stage trial for breast cancer therapy
|
| Nov 19 |
The Zacks Analyst Blog Highlights Pfizer, Newmont, Uber, Adobe and Qualcomm
|
| Nov 18 |
Jim Cramer on Pfizer Inc. (PFE): ‘Still, Anything Good There, It Could Fly’
|
| Nov 18 |
RFK Jr.'s HHS nomination sparks concern over pharma stocks
|
